|
Volumn 31, Issue 6, 2010, Pages 223-233
|
Movement disorders I: Tics and stereotypies
a b |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT;
ARIPIPRAZOLE;
BOTULINUM TOXIN;
CLOMIPRAMINE;
CLONAZEPAM;
CLONIDINE;
FLUOXETINE;
FLUPHENAZINE;
GUANFACINE;
HALOPERIDOL;
NEUROLEPTIC AGENT;
OLANZAPINE;
PIMOZIDE;
PSYCHOTROPIC AGENT;
RISPERIDONE;
SEROTONIN UPTAKE INHIBITOR;
TRICYCLIC ANTIDEPRESSANT AGENT;
ZIPRASIDONE;
ATTENTION DEFICIT DISORDER;
BEHAVIOR THERAPY;
CHOREA;
CHRONIC DISEASE;
COMORBIDITY;
DRUG INDUCED DISEASE;
DYSTONIA;
GILLES DE LA TOURETTE SYNDROME;
HUMAN;
MOTOR DYSFUNCTION;
MYOCLONUS;
OBSESSIVE COMPULSIVE DISORDER;
PARKINSONISM;
PATHOGENESIS;
PATIENT EDUCATION;
PROGNOSIS;
PSYCHOPHARMACOLOGY;
REVIEW;
SECONDARY INFECTION;
STEREOTYPIES;
STEREOTYPY;
TIC;
TREMOR;
ADOLESCENT;
AGE DISTRIBUTION;
CHILD;
DRUG THERAPY;
FEMALE;
INCIDENCE;
MALE;
MOVEMENT DISORDERS;
MULTIMODALITY CANCER THERAPY;
PRESCHOOL CHILD;
PROCEDURES;
SEX RATIO;
STEREOTYPIC MOVEMENT DISORDER;
TIC DISORDERS;
TOURETTE SYNDROME;
ADOLESCENT;
AGE DISTRIBUTION;
BEHAVIOR THERAPY;
CHILD;
CHILD, PRESCHOOL;
COMBINED MODALITY THERAPY;
DRUG THERAPY;
FEMALE;
HUMANS;
INCIDENCE;
MALE;
MOVEMENT DISORDERS;
PROGNOSIS;
SEX DISTRIBUTION;
STEREOTYPIC MOVEMENT DISORDER;
TIC DISORDERS;
TOURETTE SYNDROME;
|
EID: 77953216785
PISSN: 01919601
EISSN: 15263347
Source Type: Journal
DOI: 10.1542/pir.31-6-223 Document Type: Review |
Times cited : (31)
|
References (9)
|